LGR5 and colorectal cancer: In a large cohort, we found that a total 3% of invasive BC are positive for LGR5. Comparing this to our previous studies using the same RNA ISH technique, the positivity is similar to that in gastric cancers (7%)33 and much lower than that in colorectal cancers (68%)34.